An investigation of the use of app technology to support clinical management of patients with chronic myeloid leukaemia (CML)

Saffiya Khadam, Teresa Chu, Nigel Deekes, David FitzGerald, Andrea Preston, Nick Duncan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Downloads (Pure)

Abstract

Introduction: The availability of healthcare apps to support patient self-management of various medical conditions, including cancer, has increased considerably in the past decade. However, there are limited published data on the role of apps in the management of chronic myeloid leukaemia (CML). The primary aim of this study was to investigate the current and future role of apps as a means of supporting patients with CML. Methods: A 31-item questionnaire was developed and distributed to patients via three on-line CML support groups. Results: Responses were received from 286 patients. There was an approximate 2:1 female: male split and the majority (54%, n = 155) resided in the United Kingdom. 91% (n = 260) of respondents were currently receiving drug treatment for their CML. 23.4% (n = 67) of respondents were aware that apps were available to support their CML management and 11.5% (n = 33) had experience of using such an app. 94.1% (n = 238) of those who had not used a patient support app in the past stated that they would consider using an app in the future to help manage their disease. App awareness was significantly higher amongst male patients (30.3% vs. 19.9%). Likelihood of being a current or previous app user was higher amongst younger patients (16.3% for <55 years old vs. 5.6% for ≥55 years old) whilst younger patients and those with a more recent diagnosis of CML were both more likely to be interested in using an app in the future. When asked about potential app functionality, a drug interaction checker was the feature of greatest interest to respondents. Conclusions: We have identified both a lack of awareness of and a low uptake of patient support apps amongst CML patients. Importantly, we have demonstrated a clear interest in CML-specific apps amongst this population. Based on the functionality that study participants were most interested in, we will work with health care professionals, app developers and patients to develop a new app to deliver holistic support to CML patients.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalJournal of Oncology Pharmacy Practice
Early online date11 Apr 2022
DOIs
Publication statusE-pub ahead of print - 11 Apr 2022

Bibliographical note

Publisher Copyright:
© The Author(s) 2022.

Keywords

  • Chronic myeloid leukaemia
  • patient education
  • app technology
  • eHealth

Fingerprint

Dive into the research topics of 'An investigation of the use of app technology to support clinical management of patients with chronic myeloid leukaemia (CML)'. Together they form a unique fingerprint.

Cite this